BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36736453)

  • 1. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
    Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
    J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.
    Ismail II; Kamel WA; Kilany A
    Acta Neurol Belg; 2023 Apr; 123(2):715-716. PubMed ID: 35836090
    [No Abstract]   [Full Text] [Related]  

  • 3. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
    Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
    Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
    Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
    J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
    Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
    Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
    Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
    Emamikhah M; Babadi M; Mehrabani M; Jalili M; Pouranian M; Daraie P; Mohaghegh F; Aghavali S; Zaribafian M; Rohani M
    J Neurovirol; 2021 Feb; 27(1):26-34. PubMed ID: 33492608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
    Delap S; Shah N; Kuns O; Franklin B; Skeens MA
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and dengue virus co-infection.
    do Rosário MS; Giovanetti M; de Jesus PAP; Farias DS; Faria NR; de Lima CPS; da Silva SP; Nunes MR; Alcantara LCJ; de Siqueira IC
    Int J Infect Dis; 2018 Oct; 75():11-14. PubMed ID: 30076990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.
    Panzer JA; Anand R; Dalmau J; Lynch DR
    J Neuroimmunol; 2015 Sep; 286():86-92. PubMed ID: 26298330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.
    Fernandes J; Puhlmann P
    J Neurovirol; 2021 Jun; 27(3):501-503. PubMed ID: 33788141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis.
    Gurkas E; Gucuyener K; Yılmaz U; Havalı C; Demir E
    Pediatr Int; 2014 Dec; 56(6):e86-e87. PubMed ID: 25521990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
    Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.
    Taib BG; Kinshuck AJ; Milburn-McNulty P; Fratalia L; Forsyth L; Husband D; Jones TM; Jacob A
    J Med Case Rep; 2015 Jun; 9():128. PubMed ID: 26033370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection.
    Shah PB; Desai SD
    Neurology; 2021 Jan; 96(1):33. PubMed ID: 33004603
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
    Johnston WR; Hwang R; Mattei P
    Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
    Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.
    Bîrluţiu V; Bîrluţiu RM
    J Med Case Rep; 2014 Jun; 8():232. PubMed ID: 24968889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opsoclonus-myoclonus-ataxia syndrome: two anatomo-clinical case reports].
    Gabaldon-Torres L; Fernandez-Dominguez J; Salas-Felipe J; Caminoa-Lizarralde A; Palomo-Ferrer F; Gutierrez-Molina M; Morales-Bastos C; de Sarria-Lucas MJ; Arpa-Gutierrez FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):137-40. PubMed ID: 19206061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.